Journal article
De novo and inherited loss-of-function variants in TLK2: clinical and genotype-phenotype evaluation of a distinct neurodevelopmental disorder
- Abstract:
- Next-generation sequencing is a powerful tool for the discovery of genes related to neurodevelopmental disorders (NDDs). Here, we report the identification of a distinct syndrome due to de novo or inherited heterozygous mutations in Tousled-like kinase 2 (TLK2) in 38 unrelated individuals and two affected mothers, using whole-exome and whole-genome sequencing technologies, matchmaker databases, and international collaborations. Affected individuals had a consistent phenotype, characterized by mild-borderline neurodevelopmental delay (86%), behavioral disorders (68%), severe gastro-intestinal problems (63%), and facial dysmorphism including blepharophimosis (82%), telecanthus (74%), prominent nasal bridge (68%), broad nasal tip (66%), thin vermilion of the upper lip (62%), and upslanting palpebral fissures (55%). Analysis of cell lines from three affected individuals showed that mutations act through a loss-of-function mechanism in at least two case subjects. Genotype-phenotype analysis and comparison of computationally modeled faces showed that phenotypes of these and other individuals with loss-of-function variants significantly overlapped with phenotypes of individuals with other variant types (missense and C-terminal truncating). This suggests that haploinsufficiency of TLK2 is the most likely underlying disease mechanism, leading to a consistent neurodevelopmental phenotype. This work illustrates the power of international data sharing, by the identification of 40 individuals from 26 different centers in 7 different countries, allowing the identification, clinical delineation, and genotype-phenotype evaluation of a distinct NDD caused by mutations in TLK2.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 1.4MB, Terms of use)
-
- Publisher copy:
- 10.1016/j.ajhg.2018.04.014
Authors
+ National Institute for Health Research
More from this funder
- Grant:
- Oxford Biomedical Research Centre Programme (A.O.M.W.
+ Medical Research Council
More from this funder
- Grant:
- Weatherall Institute of Molecular Medicine Strategic Alliance (G0902418, MC_UU_12025
- Publisher:
- Cell Press
- Journal:
- American Journal of Human Genetics More from this journal
- Volume:
- 102
- Issue:
- 6
- Pages:
- 1195-1203
- Publication date:
- 2018-05-31
- Acceptance date:
- 2018-04-26
- DOI:
- ISSN:
-
0002-9297
- Keywords:
- Pubs id:
-
pubs:846588
- UUID:
-
uuid:727c7857-43b2-405e-86b9-6cfb235b5e78
- Local pid:
-
pubs:846588
- Source identifiers:
-
846588
- Deposit date:
-
2018-05-08
Terms of use
- Copyright holder:
- Reijnders et al
- Copyright date:
- 2018
- Notes:
- Copyright © 2018 The Authors. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record